JP2008545686A5 - - Google Patents

Download PDF

Info

Publication number
JP2008545686A5
JP2008545686A5 JP2008513411A JP2008513411A JP2008545686A5 JP 2008545686 A5 JP2008545686 A5 JP 2008545686A5 JP 2008513411 A JP2008513411 A JP 2008513411A JP 2008513411 A JP2008513411 A JP 2008513411A JP 2008545686 A5 JP2008545686 A5 JP 2008545686A5
Authority
JP
Japan
Prior art keywords
methoxy
dimethylamino
dihydro
chromen
tetrahydronaphthalen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008513411A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008545686A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2006/000593 external-priority patent/WO2006126939A1/en
Publication of JP2008545686A publication Critical patent/JP2008545686A/ja
Publication of JP2008545686A5 publication Critical patent/JP2008545686A5/ja
Pending legal-status Critical Current

Links

JP2008513411A 2005-05-23 2006-05-22 5ht6受容体を調節する新規な8−スルホニルアミノ−3アミノ置換クロマンまたはテトラヒドロナフタレン誘導体 Pending JP2008545686A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0501166 2005-05-23
SE0501168 2005-05-23
PCT/SE2006/000593 WO2006126939A1 (en) 2005-05-23 2006-05-22 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor

Publications (2)

Publication Number Publication Date
JP2008545686A JP2008545686A (ja) 2008-12-18
JP2008545686A5 true JP2008545686A5 (enExample) 2009-07-09

Family

ID=37452274

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008513411A Pending JP2008545686A (ja) 2005-05-23 2006-05-22 5ht6受容体を調節する新規な8−スルホニルアミノ−3アミノ置換クロマンまたはテトラヒドロナフタレン誘導体

Country Status (13)

Country Link
US (1) US20090030038A1 (enExample)
EP (1) EP1888517A1 (enExample)
JP (1) JP2008545686A (enExample)
KR (1) KR20080016810A (enExample)
AR (1) AR054363A1 (enExample)
AU (1) AU2006250117A1 (enExample)
BR (1) BRPI0610119A2 (enExample)
CA (1) CA2609747A1 (enExample)
IL (1) IL187099A0 (enExample)
MX (1) MX2007014263A (enExample)
NO (1) NO20076638L (enExample)
TW (1) TW200716529A (enExample)
WO (1) WO2006126939A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7754148B2 (en) 2006-12-27 2010-07-13 Progentech Limited Instrument for cassette for sample preparation
US7727473B2 (en) 2005-10-19 2010-06-01 Progentech Limited Cassette for sample preparation
CA2699787A1 (en) 2007-09-24 2009-04-02 Comentis, Inc. (3-hydroxy-4-amino-butan-2-yl)-3-(2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating
EP2231160B1 (en) 2007-12-04 2013-08-14 Merck Sharp & Dohme Corp. Tryptamine sulfonamides as 5-ht6 antagonists
EP2116546A1 (en) 2008-05-09 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. Substituted N-phenyl-2,3-dihydroimidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-HT6 ligands
EP2116547A1 (en) 2008-05-09 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. Substituted N-imidazo(2, 1-b) thiazole-5-sulfonamide derivatives as 5-TH6 ligands
KR20160088958A (ko) * 2010-02-23 2016-07-26 루미넥스 코포레이션 일체화된 샘플 제조, 반응 및 검출을 위한 장치 및 방법
WO2011137089A1 (en) 2010-04-29 2011-11-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Activators of human pyruvate kinase
JP5641436B2 (ja) * 2011-03-28 2014-12-17 国立大学法人 鹿児島大学 抗hiv薬
CN104023834B (zh) 2011-05-04 2016-09-28 卢米耐克斯公司 用于集成的样品制备、反应和检测的设备与方法
CN105085436B (zh) * 2014-04-19 2019-08-16 广东东阳光药业有限公司 磺酰胺类衍生物及其在药物上的应用
EP3180312B1 (en) 2014-08-12 2019-10-16 Loyola University Of Chicago Indoline sulfonamide inhibitors of dape and ndm-1 and use of the same
SG11202002032SA (en) 2017-09-22 2020-04-29 Jubilant Epipad LLC Heterocyclic compounds as pad inhibitors
CA3076476A1 (en) 2017-10-18 2019-04-25 Jubilant Epipad LLC Imidazo-pyridine compounds as pad inhibitors
BR112020008851A2 (pt) 2017-11-06 2020-10-20 Jubilant Prodel LLC composto da fórmula i, processo de preparação de compostos da fórmula i, composição farmacêutica, método para o tratamento e/ou prevenção de várias doenças, uso, método para o tratamento de câncer, método de tratamento de câncer e método para o tratamento e/ou prevenção de câncer e doenças infecciosas
PL3704120T3 (pl) 2017-11-24 2024-09-16 Jubilant Episcribe Llc Związki heterocykliczne jako inhibitory prmt5
SG11202008950PA (en) 2018-03-13 2020-10-29 Jubilant Prodel LLC Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2752659A1 (de) * 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
CH637363A5 (en) * 1977-11-24 1983-07-29 Sandoz Ag Process for preparing novel 2-aminotetralins
HUP0003073A3 (en) * 1997-07-11 2002-10-28 Smithkline Beecham Plc Benzenesulfonamide derivatives, process for producing them and their use as medicines
CA2461381A1 (en) * 2001-10-04 2003-04-10 Wyeth Chroman derivatives as 5-hydroxytryptamine-6 ligands
EP1812416B1 (en) * 2004-10-14 2013-08-21 Abbott GmbH & Co. KG Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor

Similar Documents

Publication Publication Date Title
US6515002B2 (en) Compounds and compositions for treating C1s-mediated diseases and conditions
RU2576036C2 (ru) Модуляторы активности нес1 и способы для них
RU2007107189A (ru) Производные арилпиридина
JP2013517273A5 (enExample)
RU2011147185A (ru) Азетидинилдиамиды в качестве ингибиторов моноацилглицерин-липазы
TWI691475B (zh) Urat1抑制劑
JP2013525293A5 (enExample)
HRP20100283T1 (hr) Derivati n-'(1,5-difenil-1h-pirazol-3-il)sulfonamida s afinitetom za cb1 receptor
JP2005505586A5 (enExample)
WO2002028353A2 (en) Phosphate transport inhibitors
RU2007107349A (ru) Пиперазиновые производные, применение для лечения желудочно-кишечных расстройств
CA2606804A1 (en) Antimicrobial agents
JP2005514432A5 (enExample)
RU2383533C2 (ru) Алкилированные производные пиридина в качестве ингибиторов 11-бета при диабете
JP2003531201A (ja) 炎症を治療するための2−フルオロベンゼンスルホニル化合物
JP2002536446A (ja) プロテアーゼ阻害剤としての、ヘテロアリールアミジン類、メチルアミジン類およびグアニジン類
CA2859024C (en) Benzisothiazol-3(1h)-one-5-sulfonyl derivatives as chemokine receptor modulators
US9603834B2 (en) 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
JP2016518428A5 (enExample)
JP2008115166A5 (enExample)
CN101203504B (zh) 抗微生物剂
RU2007131275A (ru) Производные n-[(4, 5-дифенил-2-тиенил)метил]сульфонамида, их получение и их применение в терапии
JP2009533315A (ja) 抗菌剤
TH80988A (th) อนุพันธ์ n-[(4,5-ไดเฟนิล-2-ไธอีนิล)เมธิล]ซัลโฟนามีด การเตรียม และการใช้สารนั้นในการรักษาโรค
TH91932A (th) สารประกอบใหม่